Finance

Lists
PVLA:NASDAQ
Palvella Therapeutics Inc
139,83 $
+1,21%
(+1,67) 1D
139,83 $
0,00% (0,00)
After hours
Closed: 28 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVLA...
Open
138,13 $
High
143,55 $
Low
137,42 $
Mkt. cap
2,01 մլրդ
Avg. vol.
207,02 հզր
Volume
0,00
52-wk high
161,38 $
52-wk low
59,16 $
EPS
-4,82 $
Beta
-0,25
Shares outstanding
14,41 մլն
No. of employees
29
Open
138,13 $
High
143,55 $
Low
137,42 $
Mkt. cap
2,01 մլրդ
Avg. vol.
207,02 հզր
Volume
0,00
52-wk high
161,38 $
52-wk low
59,16 $
EPS
-4,82 $
Beta
-0,25
Shares outstanding
14,41 մլն
No. of employees
29
News stories
From web sources and news partners
About Palvella Therapeutics Inc
CEO-
Employees29
Founded-
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to PVLA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for PVLA in the last 3 months.
Highest
Current 139,83 $
270,00 $ (+93,09%)
Average
235,22 $ (+68,22%)
Lowest
207,00 $ (+48,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gautam Chukka
Chardan Capital
Buy
Maintained
240,00 $
+71,6%
09/21/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
240,00 $
+71,6%
09/10/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
270,00 $
+93,1%
08/05/2026
Trevor Allred
Oppenheimer
Buy
Reiterated
210,00 $
+50,2%
08/05/2026
Danielle Brill
Truist Financial
Buy
Reiterated
207,00 $
+48%
08/05/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
236,00 $
+68,8%
08/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
232,00 $
+65,9%
08/05/2026
Jeet Mukherjee
BTIG
Buy
Maintained
215,00 $
+53,8%
08/04/2026
Ritu Baral
TD Cowen
Buy
Maintained
267,00 $
+90,9%
08/04/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
250,00 $
+78,8%
06/24/2026
Albert Lowe
Craig-Hallum
Buy
Reiterated
205,00 $
+46,6%
06/22/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
240,00 $
+71,6%
05/20/2026
Sudan Loganathan
Stephens
Buy
Initiated
220,00 $
+57,3%
05/11/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
220,00 $
+57,3%
03/02/2026
Catherine Novack
JonesTrading
Buy
Maintained
209,00 $
+49,5%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,53 մլն
7,12 մլն
9,33 մլն
12,47 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,65 մլն
4,18 մլն
5,52 մլն
8,93 մլն
Operating expense
10,18 մլն
11,30 մլն
14,86 մլն
21,40 մլն
Total operating expenses
10,18 մլն
11,30 մլն
14,86 մլն
21,40 մլն
Operating income
-10,18 մլն
-11,30 մլն
-14,86 մլն
-21,40 մլն
Other non operating income
-286,00 հզր
-191,00 հզր
54,00 հզր
-122,00 հզր
EBT including unusual items
-11,34 մլն
-12,71 մլն
-15,77 մլն
-21,87 մլն
EBT excluding unusual items
-11,34 մլն
-12,71 մլն
-15,77 մլն
-21,87 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,34 մլն
-12,71 մլն
-15,77 մլն
-21,87 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,03
-1,08
-1,20
-1,52
Interest and investment income
628,00 հզր
520,00 հզր
1,07 մլն
1,96 մլն
Interest expense
-1,51 մլն
-1,74 մլն
-2,04 մլն
-2,31 մլն
Net interest expenses
-882,00 հզր
-1,22 մլն
-966,00 հզր
-343,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps